Christopher Wright
Neurology · Boston, MANPI 1922065614
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,420,163 of the $2,480,995 with a category attached, or 97.5%. Every reported general payment came from a single manufacturer, Alkermes, Inc.. Reporting peaked in 2022 at $1,016,993 and has fallen 51.0% since, to $497,874 in 2025. Among neurology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $14,680 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$2.5M
What the payments were for
- Consulting fees$2,420,16398%
- Travel & lodging$55,4062%
- Food & beverage$5,4270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 169 | $2,480,995 |
How this compares
$2,480,995 in reported general payments places this provider in the 95th percentile of 761 neurology providers in Massachusetts.
Other neurology in Boston
- Thomas ScammellBoston$617K
- Alfred SandrockBoston$490K
- Pushpa NarayanaswamiBoston$420K
- Roy FreemanBoston$390K
- Michael LevyBoston$387K
- Leeann BurtonBoston$325K
- Ilena GeorgeBoston$316K
- Andrew BudsonBoston$304K
- Denis BalabanBoston$297K
- Sheena ChewBoston$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.